No-Code/Low-Code Platforms: These are the stars of the show. They let you build AI features using visual tools, not lines of ...

Natera, Inc. , a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced an advancement in molecular residual disease (MRD)-based risk stratification that is expected to ...